5 Cheap Small-Cap Stocks to Buy

4. Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS)

Number of Hedge Fund Holders: 14
Market Cap: $372.9  million
Share Price as of September 13: $5.59

Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) stands fourth on our list of the best cheap small-cap stocks to buy. It is a clinical-stage biotechnology company that develops medicines by combining protein engineering capabilities and a deep understanding of the molecular drivers of a particular disease.

In June, Jefferies lifted its price target on Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) to $8, with a ‘Buy’ rating on the shares. The firm’s analyst Roger Song noted the company’s potential in the development of PRS-220 for post-Covid-19 syndrome pulmonary fibrosis, for which Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) acquired a $17 million grant. In Q2 2021, Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) posted a GAAP EPS of -$0.25, beating the consensus by $0.02. The company also beat revenue estimates by $1.21 million at $3.29 million. After hitting a low of $1.98 per share in March 2020 due to the global economic clampdown, the stock is now traded at $5.57 per share. Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) soared 90.6% in the past year and 103.9% year to date.

As of Q2 2021, 14 hedge funds tracked by Insider Monkey have positions in Pieris Pharmaceuticals, Inc. (PIRS), worth $65.3 million. The number of hedge funds having stakes in the company remained the same in the previous quarter, with a total stake value of $36.8 million.